The tariff classification of Darifenacin Hydrochloride (CAS-103099-04-4) imported in bulk form, from India
Issued July 31, 2008 by U.S. Customs and Border Protection.
Tariff classification
HTS codes: 2934.99.3000
Headings: 2934
Product description
The subject product, Darifenacin Hydrochloride, is a medication indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency.
CBP rationale
The applicable subheading for Darifenacin Hydrochloride, imported in bulk form, will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs: Other.
Full text
N034171 July 31, 2008 CLA-2-29:OT:RR:NC:N2:238 CATEGORY: Classification TARIFF NO.: 2934.99.3000 Mr. Michael R. Tartaro Byron Chemical Company, Inc. 40-11 23rd Street Long Island City, NY 11101 RE: The tariff classification of Darifenacin Hydrochloride (CAS-103099-04-4) imported in bulk form, from India Dear Mr. Tartaro: In your letter dated July 23, 2008, you requested a tariff classification ruling. The subject product, Darifenacin Hydrochloride, is a medication indicated for the treatment of overactive bladder with symptoms of urge urinary incontinence, urgency and frequency. The applicable subheading for Darifenacin Hydrochloride, imported in bulk form, will be 2934.99.3000, Harmonized Tariff Schedule of the United States (HTSUS), which provides for "Nucleic acids and their salts, whether or not chemically defined; other heterocyclic compounds: Other: Other: Aromatic or modified aromatic: Other: Drugs: Other." Pursuant to General Note 13, HTSUS, the rate of duty will be free. Duty rates are provided for your convenience and are subject to change. The text of the most recent HTSUS and the accompanying duty rates are provided on World Wide Web at http://www.usitc.gov/tata/hts/. This product may be subject to the requirements of the Controlled Substances Act, which are enforced by the U.S. Drug Enforcement Administration (DEA), Office of Diversion Control. You may contact them at 2401 Jefferson Davis Highway, Alexandria, VA 22301, telephone (800) 882-9539. This ruling is being issued under the provisions of Part 177 of the Customs Regulations (19 C.F.R. 177). A copy of the ruling or the control number indicated above should be provided with the entry documents filed at the time this merchandise is imported. If you have any questions regarding the ruling, contact National Import Specialist Harvey Kuperstein at 646-733-3033. Sincerely, Robert B. Swierupski Director, National Commodity Specialist Division
More rulings on the same tariff codes
The tariff classification of Elinzanetant (CAS No. 929046-33-3) in bulk form and LYNKUET® (E linzanetant) Capsules in dosage form, from Germany
The tariff classification of Terazosin Hydrochloride Anhydrous (CAS No. 63074-08-8) in bulk form, from Germany
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Ozanimod (CAS No. 1306760-87-1) in bulk form, from Taiwan
The tariff classification of Cabotegravir (CAS No. 1051375-10-0) in bulk powder form, from Brazil
The tariff classification of Aprepitant (CAS No. 170729-80-3) in bulk powder form, from Spain
The tariff classification of Brexpiprazole (CAS No. 913611-97-9) in bulk power form, from Taiwan
The tariff classification of Rivaroxaban (CAS No. 366789-02-8) in bulk powder form, from Mexico
The tariff classification of Prucalopride Succinate (CAS No. 179474-85-2) in bulk form, from India
The tariff classification of Ozanimod Hydrochloride (CAS No. 1618636-37-5), Brivaracetam (CAS No. 357336-20-0) and Tofacitinib Citrate (CAS No. 540737-29-9) in bulk form, from Taiwan
Searching CBP rulings the smart way
TariffLens semantically searches all 200,000+ CBP rulings, surfaces the ones that actually match your product, and builds defensible classifications backed by ruling citations.
Book a demo →